Influenza Vaccine Market Depth Analysis and Industry Forecast, 2021–2030

The Middle East and Africa is expected to grow at a CAGR of 8.0%, owing to the increase in incidence of influenza. Increase in children and disposable income.

PORTLAND, OREGON, US, August 17, 2022 /EINPresswire.com/ -- Government support and surveillance of influenza vaccination at national and global levels to monitor the supply, distribution and administration of flu vaccines is a key factor driving the market growth. Furthermore, increased investment by leading market players worldwide and increased government funding have facilitated the launch of therapeutically effective vaccines to fuel the growth of the Influenza vaccine market.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭@ https://www.alliedmarketresearch.com/request-sample/1437

𝐆𝐞𝐭 𝐔𝐩 𝐓𝐨 𝟐𝟎% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭, 𝐓𝐢𝐥𝐥 𝐭𝐡𝐞 𝐃𝐚𝐭𝐞 𝟐𝟎𝐭𝐡 𝐨𝐟 𝐀𝐮𝐠𝐮𝐬𝐭 𝟐𝟎𝟐𝟐.

Vaccination camps and programs organized by various health care organizations have been affected due to the coronavirus pandemic. Having said that, flu vaccination rates have peaked during pandemics due to efforts by various healthcare organizations and governments to vaccinate citizens for free. Fears of flu and COVID-19 have also increased public awareness.

Developing a new vaccine is a long process that usually takes 10-15 years to develop and establish safety and efficacy. Regulatory requirements for clinical trials vary from country to country, which may delay vaccine development thereby limiting market growth.

North America was the highest revenue generating country in the global influenza vaccine market with a share of 47.80% in 2020. On the other hand, the Middle East and Africa is expected to grow at a CAGR of 8.0%, owing to the increase in incidence of influenza. Increase in children and disposable income.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲@ https://www.alliedmarketresearch.com/purchase-enquiry/1437

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝

By Vaccine Type
• Quadrivalent
• Trivalent

By Type:
• Seasonal
• Pandemic

By Technology:
• Egg-based
• Cell-based

By Route Of Administration:
• Injection
• Nasal Spray

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬
• By vaccine type, quadrivalent segment accounted for nearly 63% share of the Influenza Vaccine market in 2020.
• By technology, the egg-based segment expected to grow at a CAGR of 7.70% from 2021 to 2030.
• By age group, the adult segment held largest market share in of 61% in 2020 and is expected to remain dominant throughout the forecast period.
• By route of administration, the injection segment expected to grow at a CAGR of 7.40% from 2021 to 2030.
• By region, North America is expected to provide lucrative market growth opportunities and grow at a CAGR of 6.9% from 2021 to 2030.

𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐑𝐞𝐪𝐮𝐞𝐬𝐭@ https://www.alliedmarketresearch.com/request-for-customization/1437

𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
• Astrazeneca Plc (Astrazeneca)
• Biodiem
• Csl Limited (Seqirus GmbH)
• Emergent Biosolutions
• F. Hoffmann-La Roche Ltd.
• Gamma Vaccines Pty Ltd.
• Glaxosmithkline Plc
• Merck & Co., Inc. (Merck Sharp & Dohme Corp.)
• Novartis Ag
• Pfizer, Inc.
• Sanofi
• Sinovac Biotech Ltd.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
Implantable Insulin Pump Market
Depyrogenated Sterile Empty Vials Market

𝐖𝐞 𝐚𝐥𝐬𝐨 𝐎𝐟𝐟𝐞𝐫𝐬 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐚𝐧𝐝 𝐂𝐨𝐮𝐧𝐭𝐫𝐲 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
• North America Influenza vaccine market
• Japan Influenza vaccine market
• South Korea Influenza vaccine market
• Singapore Influenza vaccine market
• Australia Influenza vaccine market
• Europe Influenza vaccine market
• China Influenza vaccine market
• Taiwan Influenza vaccine market
• New Zealand Influenza vaccine market

𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐁𝐥𝐨𝐠:
• Biosensor Market Top Industry Players: https://southkoreahealthcarepress.blogspot.com/2022/07/south-korea-biosensor-market-top.html
• Diabetic Nephropathy Market: https://southkoreahealthcarepress.blogspot.com/2022/07/south-korea-diabetic-nephropathy-market.html
• Influenza Vaccine Market: https://southkoreahealthcarepress.blogspot.com/2022/05/influenza-vaccine-market-top-factors-to.html

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn